Skip to main content

Table 2 Comparison of SyMRI parameters of TSC patients and healthy controls

From: Synthetic MRI in children with tuberous sclerosis complex

Variables Healthy controls Tuberous sclerosis p-values
Median Min–max Median Min–max
BPV (ml) 1278 1125–1502 1202 1033–1476 .860
ICV (ml) 1400 1235–1599 1399 1176–1629 .705
WM (ml) 378 301–550 398 343–538 .561
GM (ml) 855 707–1012 821 727–996 .820
CSF (ml) 109 75–309 91 66–212 .561
MY (ml) 109 81–138 93 85–113 .118
Non-WM/GM/CSF (ml) 15 7.7–65 20 15–43 .035*
%Non/BPV 1.15 0.6–4.7 1.6 1.1–3.1 .049*
%MY/ICV 7.8 6.4–9.4 6.7 5.9–9 .05*
%MY/BPV 8.7 6.9–10 7.7 6.8–9.7 .035*
%Non/ICV 1.1 0.6–4.3 1.5 1–2.7 .050*
R NABP MyC 28.55 24.8–34.8 25.6 22–30 .035*
R NABP PD 66.9 62.8–69.4 68.9 66–71.2 .023*
L NABP MyCvol 0.18 0.10–0.20 0.16 0.14–0.19 .017*
L NABP MyC 28.5 24.6–32.3 26 23.5–29.9 .001*
L NABP PD 66.9 64–69 68.6 66–70 .001*
R Caudate MyC 7.2 4.5–8.7 5.35 2–7.3 .004*
R Caudate PD 81 79.8–82.7 82.2 80.8–86.7 .005*
L Caudate MyC 5.2 1–8.3 7.2 5.7–10 .004*
L Caudate PD 80.7 79.1–82 81.9 79.5–85.4 .023*
L Thalamus MyCvol 0.07 0.04–0.10 0.055 0.03–0.09 .009*
Pons MyCvol 0.09 0.07–0.12 0.07 0.06–0.09 .000*
Pons MYC 21.85 18–29 16.7 13.6–20.4 .000*
Pons PD 70.95 66.1–74 74.7 69.4–76.7 .002*
  1. Units: MY (ml), R1 and R2 (s-1), BPV (ml), ICV (ml), WM (ml), GM (ml), PD (pu)
  2. *Represents significance is < 0.05